Rouvier E, Luciani M-F, Mattei M-G, Denizot F, Golstein P: CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a Herpesvirus Saimiri gene. J Immunol. 1993, 150: 5445-5456.
CAS
PubMed
Google Scholar
Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, Pin J-J, Garrone P, Garcia E, Saeland S, et al: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996, 183: 2593-2603. 10.1084/jem.183.6.2593.
Article
CAS
PubMed
Google Scholar
Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ: Cutting Edge: Human IL-17: A novel cytokine derived from T cells. J Immunol. 1995, 155: 5483-5486.
CAS
PubMed
Google Scholar
Yao Z, Spriggs MK, Derry JMJ, Strockbine L, Park LS, VandenBos T, Zappone J, Painter SL, Armitage RJ: Molecular characterization of the human interleukin-17 receptor. Cytokine. 1997, 9: 794-800. 10.1006/cyto.1997.0240.
Article
CAS
PubMed
Google Scholar
Tsang M, Friesel R, Kudoh T, Dawid IB: Identification of Sef, a novel modulator of FGF signalling. Nat Cell Biol. 2002, 4: 165-169. 10.1038/ncb749.
Article
CAS
PubMed
Google Scholar
Yang RB, Ng CK, Wasserman SM, Komuves LG, Gerritsen ME, Topper JN: A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling. J Biol Chem. 2003, 278: 33232-33238. 10.1074/jbc.M305022200.
Article
CAS
PubMed
Google Scholar
Xiong S, Zhao Q, Rong Z, Huang G, Huang Y, Chen P, Zhang S, Liu L, Chang Z: hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling. J Biol Chem. 2003, 278: 50273-50282. 10.1074/jbc.M306936200.
Article
CAS
PubMed
Google Scholar
Aggarwal S, Gurney AL: IL-17: A prototype member of an emerging cytokine family. J Leukoc Biol. 2002, 71: 1-8.
CAS
PubMed
Google Scholar
Eberl M: Don't count your interleukins before they've hatched. Trends Immunol. 2002, 23: 341-342. 10.1016/S1471-4906(02)02239-1.
Article
CAS
PubMed
Google Scholar
Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P, Maruoka M, Mao W, Foster J, Kelley RF, et al: IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 2001, 20: 5332-5341. 10.1093/emboj/20.19.5332.
Article
PubMed Central
CAS
PubMed
Google Scholar
Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, Barber MC, Wang W, Wathen K, Hodge V, Fisher CL, et al: A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem. 2000, 275: 19167-19176. 10.1074/jbc.M910228199.
Article
CAS
PubMed
Google Scholar
Yao Z, Fanslow WC, Seldin MF, Rousseau A-M, Painter SL, Comeau MR, Cohen JI, Spriggs MK: Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995, 3: 811-821. 10.1016/1074-7613(95)90070-5.
Article
CAS
PubMed
Google Scholar
Shin HC, Benbernou N, Fekkar H, Esnault S, Guenounou M: Regulation of IL-17, IFN-gamma and IL-10 in human CD8 + T cells by cyclic AMP-dependent signal transduction pathway. Cytokine. 1998, 10: 841-850. 10.1006/cyto.1998.0375.
Article
CAS
PubMed
Google Scholar
Shin HC, Benbernou N, Esnault S, Guenounou M: Expression of IL-17 in human memory CD45RO+ T lymphocytes and its regulation by protein kinase A pathway. Cytokine. 1999, 11: 257-266. 10.1006/cyto.1998.0433.
Article
CAS
PubMed
Google Scholar
Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD: Interleukin-17 and interferon-γ synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol. 1998, 111: 645-649. 10.1046/j.1523-1747.1998.00347.x.
Article
CAS
PubMed
Google Scholar
Aarvak T, Chabaud M, Miossec P, Natvig JB: IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol. 1999, 162: 1246-1251.
CAS
PubMed
Google Scholar
Chabaud M, Page G, Miossec P: Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol. 2001, 167: 6015-6020.
Article
CAS
PubMed
Google Scholar
Albanesi C, Cavani A, Girolomoni G: IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonistic effects with IFN-γ and TNF-α. J Immunol. 1999, 162: 494-502.
CAS
PubMed
Google Scholar
Infante-Duarte C, Horton HF, Byrne MC, Kamradt T: Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol. 2000, 165: 6107-6115.
Article
CAS
PubMed
Google Scholar
Happel KI, Zheng M, Young E, Quinton LJ, Lockhart E, Ramsay AJ, Shellito JE, Schurr JR, Bagby GJ, Nelson S, et al: Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol. 2003, 170: 4432-4436.
Article
PubMed Central
CAS
PubMed
Google Scholar
Aggarwal S, Ghilardi N, Xie MH, De Sauvage FJ, Gurney AL: Interleukin 23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin 17. J Biol Chem. 2003, 278: 1910-1914. 10.1074/jbc.M207577200.
Article
CAS
PubMed
Google Scholar
Ghilardi N, Kljavin N, Chen Q, Lucas S, Gurney A, de Sauvage FJ: Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J Immunol. 2004, 172: 2827-2833.
Article
CAS
PubMed
Google Scholar
Ziolkowska M, Koc A, Luszczukiewicz G, Ksiezopolksa-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, Maslinski W: High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol. 2000, 164: 2832-2838.
Article
CAS
PubMed
Google Scholar
Moseley TA, Haudenschild DR, Rose L, Reddi AH: Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 2003, 14: 155-174. 10.1016/S1359-6101(03)00002-9.
Article
CAS
PubMed
Google Scholar
Liu X, Lin X, Gaffen SL: Crucial role for nuclear factor of activated T cells (NFAT) in T cell receptor-mediated regulation of the human interleukin-17 gene. J Biol Chem. 2004, Sep 30,
Sheridan CM, Heist EK, Beals CR, Crabtree GR, Gardner P: Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3. J Biol Chem. 2002, 277: 48664-48676. 10.1074/jbc.M207029200.
Article
CAS
PubMed
Google Scholar
Yao Z, Timour M, Painter S, Fanslow W, Spriggs M: Complete nucleotide sequence of the mouse CTLA8 gene. Gene. 1996, 168: 223-225. 10.1016/0378-1119(95)00778-4.
Article
CAS
PubMed
Google Scholar
Lindsten T, June CH, Ledbetter JA, Stella G, Thompson CB: Regulation of lymphokine messenger RNA stability by a surface-mediated T-cell activation pathway. Science. 1989, 244: 339-343.
Article
CAS
Google Scholar
Miossec P: Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 2003, 48: 594-601. 10.1002/art.10816.
Article
CAS
PubMed
Google Scholar
Laan M, Cui A-H, Hoshino H, Lötvall J, Sjöstrand M, Gruenert DC, Skoogh B-E, Lindén A: Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999, 162: 2347-2352.
CAS
PubMed
Google Scholar
Maertzdorf J, Osterhaus AD, Verjans GM: IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J Immunol. 2002, 169: 5897-5903.
Article
CAS
PubMed
Google Scholar
Van Bezooijen RL, Papapoulos SE, Lowik CW: Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling?. Bone. 2001, 28: 378-386. 10.1016/S8756-3282(00)00457-9.
Article
CAS
PubMed
Google Scholar
Witowski J, Pawlaczyk K, Breborowicz A, Scheuren A, Kuzlan-Pawlaczyk M, Wisniewska J, Polubinska A, Friess H, Gahl GM, Frei U, et al: IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol. 2000, 165: 5814-5821.
Article
CAS
PubMed
Google Scholar
Ruddy MJ, Shen F, Smith J, Sharma A, Gaffen SL: Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol. 2004, 76: 135-144. 10.1189/jlb.0204065.
Article
CAS
PubMed
Google Scholar
Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, Gaffen SL: Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer binding protein family members. J Biol Chem. 2004, 279: 2559-2567. 10.1074/jbc.M308809200.
Article
CAS
PubMed
Google Scholar
Woltman AM, de Haij S, Boonstra JG, Gobin SJ, Daha MR, van Kooten C: Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol. 2000, 11: 2044-2055.
CAS
PubMed
Google Scholar
Takaya H, Andoh A, Makino J, Shimada M, Tasaki K, Araki Y, Bamba S, Hata K, Fujiyama Y, Bamba T: Interleukin-17 stimulates chemokine (interleukin-8 and monocyte chemoattractant protein-1) secretion in human pancreatic periacinar myofibroblasts. Scand J Gastroenterol. 2002, 37: 239-245. 10.1080/003655202753416948.
Article
CAS
PubMed
Google Scholar
Eickelberg O, Pansky A, Mussmann R, Bihl M, Tamm M, Hilde-brand P, Perruchoud AP, Roth M: Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem. 1999, 274: 12933-12938. 10.1074/jbc.274.18.12933.
Article
CAS
PubMed
Google Scholar
Tokuda H, Kanno Y, Ishisaki A, Takenaka M, Harada A, Kozawa O: Interleukin (IL)-17 enhances tumor necrosis factor-alpha-stimulated IL-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts. J Cell Biochem. 2004, 91: 1053-1061. 10.1002/jcb.20004.
Article
CAS
PubMed
Google Scholar
Baker P: The role of immune responses in bone loss during periodontal disease. Microbes Infect. 2000, 2: 1181-1192. 10.1016/S1286-4579(00)01272-7.
Article
CAS
PubMed
Google Scholar
Theill L, Boyle W, Penninger J: RANK-L and RANK: T cells, bone loss and mammalian evolution. Annu Rev Immunol. 2002, 20: 795-823. 10.1146/annurev.immunol.20.100301.064753.
Article
CAS
PubMed
Google Scholar
Ducy P, Schinke T, Karsenty G: The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000, 289: 1501-1504. 10.1126/science.289.5484.1501.
Article
CAS
PubMed
Google Scholar
Teitelbaum S: Bone resorption by osteoclasts. Science. 2000, 289: 1504-1508. 10.1126/science.289.5484.1504.
Article
CAS
PubMed
Google Scholar
Rodan GA, Martin TJ: Therapeutic approaches to bone diseases. Science. 2000, 289: 1508-1514. 10.1126/science.289.5484.1508.
Article
CAS
PubMed
Google Scholar
Nakashima T, Wada T, Penninger JM: RANKL and RANK as novel therapeutic targets for arthritis. Curr Opin Rheumatol. 2003, 15: 280-287. 10.1097/00002281-200305000-00016.
Article
CAS
PubMed
Google Scholar
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998, 93: 165-176. 10.1016/S0092-8674(00)81569-X.
Article
CAS
PubMed
Google Scholar
Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli S, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, et al: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999, 397: 315-323. 10.1038/16852.
Article
CAS
PubMed
Google Scholar
Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, et al: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA. 2000, 97: 1566-1571. 10.1073/pnas.97.4.1566.
Article
PubMed Central
CAS
PubMed
Google Scholar
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, et al: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997, 89: 309-319. 10.1016/S0092-8674(00)80209-3.
Article
CAS
PubMed
Google Scholar
Grcevic D, Katavic V, Lukic IK, Kovacic N, Lorenzo JA, Marusic A: Cellular and molecular interactions between immune system and bone. Croat Med J. 2001, 42: 384-392.
CAS
PubMed
Google Scholar
Kong Y-Y, Gelge U, Sarosi H, Bolon B, Tafuri A, Morony S, Cappareli C, Li J, Elliott R, McCabe S, et al: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999, 402: 304-309. 10.1038/46303.
Article
CAS
PubMed
Google Scholar
Nakashima T, Kobayashi Y, Yamasaki S, Kawakami A, Eguchi K, Sasaki H, Sakai H: Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun. 2000, 275: 768-775. 10.1006/bbrc.2000.3379.
Article
CAS
PubMed
Google Scholar
Choy EH, Panayi GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001, 344: 907-916. 10.1056/NEJM200103223441207.
Article
CAS
PubMed
Google Scholar
van Bezooijen RL, Farih-Sips HCM, Papapoulos SE, Löwik CWGM: Interleukin-17: a new bone acting cytokine in vitro. J Bone Miner Res. 1999, 14: 1513-1521.
Article
CAS
PubMed
Google Scholar
Johnson RB, Wood N, Serio FG: Interleukin-11 and IL-17 and the pathogenesis of periodontal disease. J Periodontol. 2004, 75: 37-43. 10.1902/jop.2004.75.1.37.
Article
CAS
PubMed
Google Scholar
Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin 17: a T cell-derived proinflam-matory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999, 42: 963-970. 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E.
Article
CAS
PubMed
Google Scholar
Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB: IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol. 2003, 170: 2655-2662.
Article
CAS
PubMed
Google Scholar
Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol. 2003, 171: 6173-6177.
Article
CAS
PubMed
Google Scholar
Lubberts E, Joosten LAB, Chabaud M, van den Bersselaar L, Oppers B, Coenen-de Roo CJJ, Richards CD, Miossec P, van den Berg WB: IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest. 2000, 105: 1697-1710.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum. 2004, 50: 650-659. 10.1002/art.20001.
Article
CAS
PubMed
Google Scholar
Chabaud M, Lubberts E, Joosten L, van Den Berg W, Miossec P: IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 2001, 3: 168-177. 10.1186/ar294.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB: IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol. 2001, 167: 1004-1013.
Article
CAS
PubMed
Google Scholar
Lubberts E, Joosten LA, van de Loo FA, Schwarzenberger P, Kolls J, van den Berg WB: Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm Res. 2002, 51: 102-104.
Article
CAS
PubMed
Google Scholar
Lubberts E, Joosten LA, van de Loo FA, van den Gersselaar LA, van den Berg WB: Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4. Arthritis Rheum. 2000, 43: 1300-1306. 10.1002/1529-0131(200006)43:6<1300::AID-ANR12>3.0.CO;2-D.
Article
CAS
PubMed
Google Scholar
Nurieva RI, Treuting P, Duong J, Flavell RA, Dong C: Inducible costimulator is essential for collagen-induced arthritis. J Clin Invest. 2003, 111: 701-706.
Article
PubMed Central
CAS
PubMed
Google Scholar
McCauley LK: Transgenic mouse models of metabolic bone disease. Curr Opin Rheumatol. 2001, 13: 316-325. 10.1097/00002281-200107000-00014.
Article
CAS
PubMed
Google Scholar
Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas S: Increased osteoclast development after estrogen loss: mediated by interleukin-6. Science. 1992, 257: 88-91.
Article
CAS
PubMed
Google Scholar
Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC: CD4+ T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun. 1999, 67: 2804-2809.
PubMed Central
CAS
PubMed
Google Scholar
Page R, Kornman K, editors: Periodontology 2000. 1997, Copenhagen: Munksgaard
Google Scholar
Kantarci A, Oyaizu K, Van Dyke TE: Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol. 2003, 74: 66-75. 10.1902/jop.2003.74.1.66.
Article
CAS
PubMed
Google Scholar
Baker PJ, DuFour L, Dixon M, Roopenian DC: Adhesion molecule deficiencies increase Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect Immun. 2000, 68: 3103-3107. 10.1128/IAI.68.6.3103-3107.2000.
Article
PubMed Central
CAS
PubMed
Google Scholar
Knappe A, Hiller C, Niphuis H, Fossiez F, Thurau M, Wittmann S, Kuhn EM, Lebecque S, Banchereau J, Rosenwirth B, et al: The interleukin-17 gene of herpesvirus saimiri. J Virol. 1998, 72: 5797-5801.
PubMed Central
CAS
PubMed
Google Scholar
Patera AC, Pesnicak L, Bertin J, Cohen JI: Interleukin 17 modulates the immune response to vaccinia virus infection. Virology. 2002, 299: 56-63. 10.1006/viro.2002.1400.
Article
CAS
PubMed
Google Scholar
Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, Sastre-Garau X, Couturier J, Mosseri V, Vives V, et al: Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 1999, 59: 3698-3704.
CAS
PubMed
Google Scholar
Benchetrit F, Ciree A, Vives V, Warnier G, Gey A, Sautes-Fridman C, Fossiez F, Haicheur N, Fridman WH, Tartour E: Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood. 2002, 99: 2114-2121. 10.1182/blood.V99.6.2114.
Article
CAS
PubMed
Google Scholar
Luzza F, Parrello T, Monteleone G, Sebkova L, Romano M, Zarrilli R, Imeneo M, Pallone F: Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol. 2000, 165: 5332-5337.
Article
CAS
PubMed
Google Scholar
Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzen-berger P, Oliver P, Huang W, Zhang P, Zhang J, et al: Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001, 194: 519-527. 10.1084/jem.194.4.519.
Article
PubMed Central
CAS
PubMed
Google Scholar
Linden A, Adachi M: Neutrophilic airway inflammation and IL-17. Allergy. 2002, 57: 769-775. 10.1034/j.1398-9995.2002.02164.x.
Article
CAS
PubMed
Google Scholar
Schwarzenberger P, La Russa V, Miller A, Ye P, Huang W, Zieske A, Nelson S, Bagby GJ, Stoltz S, Mynatt RL, et al: IL-17 stimulates granulopoiesis in mice: Use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol. 1998, 161: 6383-6389.
CAS
PubMed
Google Scholar
Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, Sekikawa K, Asano M, Iwakura Y: Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002, 17: 375-387. 10.1016/S1074-7613(02)00391-6.
Article
CAS
PubMed
Google Scholar
Pan G, French D, Mao W, Maruoka M, Risser P, Lee J, Foster J, Aggarwal S, Nicholes K, Guillet S, et al: Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol. 2001, 167: 6559-6567.
Article
CAS
PubMed
Google Scholar
Ozaki K, Leonard WJ: Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem. 2002, 277: 29355-29358. 10.1074/jbc.R200003200.
Article
CAS
PubMed
Google Scholar
Pullen SS, Dang TT, Crute JJ, Kehry MR: CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem. 1999, 274: 14246-14254. 10.1074/jbc.274.20.14246.
Article
CAS
PubMed
Google Scholar
Schwandner R, Yamaguchi K, Cao Z: Requirement of tumor necrosis factor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med. 2000, 191: 1233-1239. 10.1084/jem.191.7.1233.
Article
PubMed Central
CAS
PubMed
Google Scholar
Akira S: Toll-like receptors and innate immunity. Adv Immunol. 2001, 78: 1-56. 10.1016/S0065-2776(01)78001-7.
Article
CAS
PubMed
Google Scholar
Faour WH, Mancini A, He QW, Di Battista JA: T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3'-untranslated region of COX-2 mRNA. J Biol Chem. 2003, 278: 26897-26907. 10.1074/jbc.M212790200.
Article
CAS
PubMed
Google Scholar